Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04NOT
|
|||
| Former ID |
DIB019022
|
|||
| Drug Name |
bromoacetone
|
|||
| Synonyms |
martonite; monobromoacetone; acetonyl bromide
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL
|
||
| Formula |
C3H5BrO
|
|||
| Canonical SMILES |
CC(=O)CBr
|
|||
| InChI |
1S/C3H5BrO/c1-3(5)2-4/h2H2,1H3
|
|||
| InChIKey |
VQFAIAKCILWQPZ-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 598-31-2
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
589568, 8158625, 10528979, 15120006, 29279996, 50023742, 57269726, 57327114, 79379629, 85247537, 88822883, 103756793, 104152874, 104326883, 104759422, 118046465, 125308557, 125354032, 126546435, 126644668, 126689370, 127307368, 127307369, 128511114, 129511308, 131320346, 134975986, 137003989, 142296233, 143491008, 152233273, 160809029, 162220588, 162266029, 162760378, 163395316, 163774912, 163808669, 164785496, 176328437, 178102913, 184577470, 198938327, 201503243, 204378295, 223386722, 223492872, 223517237, 223675500, 223772153
|
|||
| ChEBI ID |
CHEBI:51845
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Transformation-sensitive protein p120 (TRPA1) | Target Info | Activator | [2] |
| KEGG Pathway | Inflammatory mediator regulation of TRP channels | |||
| Reactome | TRP channels | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6293). | |||
| REF 2 | Transient receptor potential ankyrin 1 antagonists block the noxious effects of toxic industrial isocyanates and tear gases. FASEB J. 2009 Apr;23(4):1102-14. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.